215 results on '"Howard, Dianna S."'
Search Results
2. Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma
3. Phase II trial of cytarabine and mitoxantrone with devimistat in acute myeloid leukemia
4. Efficacy of 10-day decitabine in acute myeloid leukemia
5. Asking the "Right" Questions about Financial Hardship: Using Cognitive Interviews with Adolescents and Young Adults with Cancer and Their Caregivers to Inform Measure Development.
6. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study
7. In Pursuit of Optimal Outcomes: A Framework for Quality Standards in Immune Effector Cell Therapy
8. Riding the Wave: Risk Factors for Acute Kidney Injury in Patients Receiving Ptcy with Hyperhydration
9. Donor Search and Selection Strategy to Facilitate Comparable Transplant Rates across Donor Search Prognosis Groups: A Report from the BMT CTN 1702 Trial
10. SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)
11. Cultural and linguistic adaptation of a telephone-based cognitive-behavioral therapy (CBT) intervention to treat depression and anxiety in Hispanic cancer survivors.
12. Cultural and linguistic adaptation of a telephone-based cognitive-behavioral therapy (CBT) intervention to treat depression and anxiety in Hispanic cancer survivors
13. Preferential Induction of Apoptosis for Primary Human Leukemic Stem Cells
14. Adenovirus Infections in Hematopoietic Stem Cell Transplant Recipients
15. Final outcomes of escalated melphalan 280 mg/m2 with amifostine cytoprotection followed autologous hematopoietic stem cell transplantation for multiple myeloma: high CR and VGPR rates do not translate into improved survival
16. Breaking the Age Barrier: Physicians’ Perceptions of Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults
17. Supplemental Materials from A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia
18. Haploidentical Transplant Using a Novel Preparative Regimen: An Update on a New Standard of Care for Patients without HLA Matched Donors
19. A phase 2 trial of azacitidine and gemtuzumab ozogamicin therapy in older patients with acute myeloid leukemia
20. A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemia
21. Financial burden for caregivers of adolescents and young adults with cancer
22. A Multi-Center Collaborative Study of Outcomes of TP53-Mutated MDS/AML Patients Following Allogeneic HCT
23. Feasibility Study of Telemedicine for Outpatient Chimeric Antigen Receptor (CAR) T-Cell Program
24. Haploidentical Transplant Using a Novel Preparative Regimen: A New Standard of Care for Patients without HLA Matched Donors
25. Non-Relapse Mortality in TP53-Mutated MDS/AML - a Multi-Center Collaborative Study
26. Stakeholder‐informed conceptual framework for financial burden among adolescents and young adults with cancer
27. A Phase 2 study of bortezomib combined with either idarubicin/cytarabine or cytarabine/etoposide in children with relapsed, refractory or secondary acute myeloid leukemia: A report from the Childrenʼs Oncology Group
28. Systematic review of financial burden assessment in cancer: Evaluation of measures and utility among adolescents and young adults and caregivers
29. The Unified Approach to Treatment Center and CIBMTR Supports More Complete Information to Advance Therapies
30. Development of a CAR-T Program from Inception to Implementation: Moving from a Novice to an Expert
31. Letermovir Prophylaxis and the Effect on Cytomegalovirus (CMV) Infection
32. Collaborative, Agile Partnerships Are Critical to Successful BMT Quality Programs
33. Development and Implementation of Outpatient CAR-T Program at the Wake Forest Baptist Comprehensive Cancer Center
34. BEAM Conditioning for ASCT in High-Risk Geriatric Patients
35. Outcomes Following Reinduction Therapy for Relapsed Acute Myeloid Leukemia Post Allogeneic Hematopoietic Cell Transplantation
36. A Pilot Phase II Study of the Feasibility and Efficacy of Vincristine Sulfate Liposome Injection in Patients With Relapsed or Refractory Acute Myeloid Leukemia
37. Frontline Selinexor and Chemotherapy Is Highly Active in Older Adults with Acute Myeloid Leukemia (AML)
38. 313 - Haploidentical Transplant Using a Novel Preparative Regimen: An Update on a New Standard of Care for Patients without HLA Matched Donors
39. BK virus nephropathy after allogeneic stem cell transplantation: A case report and literature review
40. Stakeholder‐informed conceptual framework for financial burden among adolescents and young adults with cancer.
41. Use of a T cell-specific monoclonal antibody, T10B9, in a novel allogeneic stem cell transplantation protocol for hematologic malignancy high-risk patients
42. Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer
43. Transplant Physicians’ Attitudes on Candidacy for Allogeneic Hematopoietic Cell Transplantation (HCT) in Older Patients: The Need for a Standardized Geriatric Assessment (GA) Tool
44. Devimistat Induces Mitophagy and Chemosensitization Resulting in Increases in Survival in Older But Not Younger AML Patients
45. Evaluating the Utilization of All-Trans Retinoic Acid and Arsenic Trioxide during Consolidation Therapy for Patients Receiving Treatment for Acute Promyelocytic Leukemia
46. Assessing Efficacy and Safety of Daunorubicin and Cytarabine Liposomal in Patients with Acute Myeloid Leukemia
47. Selinexor in Combination with Induction and Consolidation Therapy in Older Adults with AML Is Highly Active
48. 595 - Feasibility Study of Telemedicine for Outpatient Chimeric Antigen Receptor (CAR) T-Cell Program
49. 335 - Haploidentical Transplant Using a Novel Preparative Regimen: A New Standard of Care for Patients without HLA Matched Donors
50. 46 - A Multi-Center Collaborative Study of Outcomes of TP53-Mutated MDS/AML Patients Following Allogeneic HCT
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.